Skip to search formSkip to main contentSkip to account menu
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.
TLDR
Administration of Recombinant Erythropoietin Determines increase of Peripheral Resistances in patients with Hypovolemic Shock and the importance of following up with anesthesia and Resuscitation department is unclear.
View on PubMed
Chemoprevention of prostate cancer by isoflavonoids.
In Europe, prostate cancer (PC) is the most common malignancy in males. There are three known risk factors strongly coherent to the development of PC: heredity, ethnical origin, and age. Migration…
View on PubMed
861 Chemopreventive properties of the flavonoids genistein and quercetin in men with rising PSA: First results of a double-blind, randomized, placebo-controlled trial (QUERGEN trial)
View via Publisher
HT7 - A REVIEW OF EFFICIENCY OPINIONS OF FRENCH ‘HAUTE AUTORITE DE SANTE’ (HAS) IN THE ONCOLOGY FIELD
View via Publisher
PCN355 - UTILITY IN FRENCH HEALTH-ECONOMIC OPINIONS: KEY LEARNINGS OF A RETROSPECTIVE ANALYSIS IN ONCOLOGY DRUGS
View via Publisher
800 CHEMOPREVENTIVE PROPERTIES OF THE FLAVONOIDS GENISTEIN AND QUERCETIN IN MEN WITH RISING PSA: FIRST RESULTS OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (QUERGEN TRIAL)
View via Publisher
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License